Akums combines two potent diabetes medicines for enhanced treatment efficacy: Our Bureau, Bengaluru Tuesday, February 4, 2025, 15:30 Hrs [IST] Akums Drugs and Pharmaceuticals, a l ...

Objective: To evaluate the effect of combination therapy with pioglitazone and glucagon-like peptide (GLP)-1 in patients with type 2 diabetes. Conclusions: GLP-1 and pioglitazone show an additive ...

There are two drugs in this class: pioglitazone (Actos) and rosiglitazone (Avandia), and both were approved by the FDA in 1999. A third drug in this class, troglitazone (Rezulin), was approved in ...

To assess whether pioglitazone (Actos) can prevent or slow progression to diabetes, Texas researchers randomized 602 patients with impaired glucose tolerance to placebo or pioglitazone (starting ...